Making prescription refills more affordable and easier to get may reduce disparities among hypertension patients, according to a study.
An observational study using electronic medical record data of more than 44,000 patients recently diagnosed with high blood pressure in Kaiser Permanente Northern California identified important differences in medicine-taking behaviors among racial and ethnic groups. Lower copayments and the use of mail-order pharmacy increased refills of blood-pressure medicine, and these factors were associated with reduced disparities.
“We identified patients at the time they initiated therapy and followed their health services use for 1 year,” lead author Alyce C. Adams, PhD, research scientist with the Kaiser Permanente Division of Research, told Formulary.
“In an integrated healthcare setting with comprehensive hypertension care services, we found that reduced copays and participation in mail-order pharmacy, which included a reduced copayment for some members, were associated with reduced gaps in medication adherence by race and ethnicity,” she said.
Primary nonadherence, or failing to pick up a prescribed medication, was rare. More than one-third of patients failed to refill a medication within 90 days of the first fill, and this varied considerably by race. After adjusting for other variables, black (43.6%), Asian (38.8%), and Latino (41.6%) patients all had significantly higher odds of early nonpersistence than white (31%) patients.
Nonadherent patients were defined as those with gaps in medication refills for more than 20% of the days in the measurement period, or having medication available less than 80% of the time. Of the nonadherent patients studied, 28% were black, 26.9% were Latino, 20.3% were Asian, and 16.7% were white. The impact of race and ethnicity on nonadherence was significantly reduced when the authors accounted for differences in copayment and enrollment in mail-order pharmacy; both mail-order pharmacy enrollment and lower copayments were significantly associated with a lower likelihood of being nonadherent.
“Previous studies have identified racial and ethnic differences in medication adherence, but few provide any guidance to healthcare systems in how to address these differences,” according to Adams. “We set out to identify modifiable factors that can be used in interventions to address disparities in hypertension.”
CARDIOVASCULAR DISPARITIES
Medication nonadherence is a critical challenge in efforts to improve cardiovascular disparities, according to Adams. “This study suggests that these disparities are not unalterable and that copay reduction and mail order pharmacy are potential tools in disparities intervention efforts,” she said.
However, the context in which these interventions are employed is also important, Adams said. “Kaiser Permanente Northern California has had tremendous success in treating hypertension over the past decade with 87% of its members with hypertension being in control.
“These findings suggest that health system interventions that ease access to medications may be important tools in efforts to reduce persistent disparities in medication adherence among patients newly treated for hypertension,” Adams added.
Coalition promotes important acetaminophen dosing reminders
November 18th 2014It may come as a surprise that each year Americans catch approximately 1 billion colds, and the Centers for Disease Control and Prevention estimates that as many as 20% get the flu. This cold and flu season, 7 in 10 patients will reach for an over-the-counter (OTC) medicine to treat their coughs, stuffy noses, and sniffles. It’s an important time of the year to remind patients to double check their medicine labels so they don’t double up on medicines containing acetaminophen.
Support consumer access to specialty medications through value-based insurance design
June 30th 2014The driving force behind consumer cost-sharing provisions for specialty medications is the acquisition cost and not clinical value. This appears to be true for almost all public and private health plans, says a new report from researchers at the University of Michigan Center for Value-Based Insurance Design (V-BID Center) and the National Pharmaceutical Council (NPC).
Management of antipsychotic medication polypharmacy
June 13th 2013Within our healthcare-driven society, the increase in the identification and diagnosis of mental illnesses has led to a proportional increase in the prescribing of psychotropic medications. The prevalence of mental illnesses and subsequent treatment approaches may employ monotherapy as first-line treatment, but in many cases the use of combination of therapy can occur, leading to polypharmacy.1 Polypharmacy can be defined in several ways but it generally recognized as the use of multiple medications by one patient and the most common definition is the concurrent use of five more medications. The presence of polyharmacy has the potential to contribute to non-compliance, drug-drug interactions, medication errors, adverse events, or poor quality of life.
Medical innovation improves outcomes
June 12th 2013I have been diagnosed with stage 4 cancer of the pancreas, a disease that’s long been considered not just incurable, but almost impossible to treat-a recalcitrant disease that some practitioners feel has given oncology a bad name. I was told my life would be measured in weeks.